Form 4: ATAI Life Sciences CEO Sells Shares to Cover Tax Obligations

CEO Srinivas Rao sold 75,418 common shares of ATAI Life Sciences N.V. on March 21, 2025, at a price of $1.35 per share to cover tax liabilities related to vesting restricted stock units.

Summary

• On March 21, 2025, Srinivas Rao, the CEO of ATAI Life Sciences N.V., sold 75,418 common shares of the company.
• The shares were sold at a price of $1.35 per share.
• The sale was executed to satisfy the reporting person's tax liability on the vesting of restricted stock units.
• Following the transaction, Rao directly owns 212,942 common shares.
• Rao also indirectly owns 3,500 common shares through his spouse.

Sentiment

Score: 6

Explanation: The document is a standard SEC filing related to a share sale for tax purposes. It doesn't inherently indicate positive or negative sentiment, but the fact that the CEO is selling shares, even for tax reasons, could be perceived slightly negatively by some investors.

Industry Context

Executive share sales are a common occurrence, often related to personal financial planning or tax obligations. The impact on the stock price can vary depending on the size of the sale and the market's perception of the company's prospects.

Stakeholder Impact

• The share sale could have a minor impact on shareholders, potentially causing a slight decrease in the stock price due to increased selling pressure.

Key Dates

Keywords

ATAI Life Sciences, Srinivas Rao, CEO, share sale, Form 4, restricted stock units, tax liability, beneficial ownership